share_log

Maxim Group Initiates Coverage On OS Therapies With Buy Rating, Announces Price Target of $8

Maxim Group Initiates Coverage On OS Therapies With Buy Rating, Announces Price Target of $8

Maxim集团对OS疗法启动覆盖,给予买入评级,宣布目标价为8美元。
Benzinga ·  11/26 22:54  · 评级/大行评级

Maxim Group analyst Jason McCarthy initiates coverage on OS Therapies (AMEX:OSTX) with a Buy rating and announces Price Target of $8.

Maxim集团分析师杰森·麦卡锡以买入评级启动了对OS Therapies(AMEX: OSTX)的报道,并宣布目标股价为8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发